{"id":"https://openalex.org/W4230809397","doi":"https://doi.org/10.2174/187152007781668724","title":"Recent Advances in Classical and Non-Classical Antifolates as Antitumor and Antiopportunistic Infection Agents: Part I","display_name":"Recent Advances in Classical and Non-Classical Antifolates as Antitumor and Antiopportunistic Infection Agents: Part I","alternate_titles":[],"publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W4230809397","doi":"https://doi.org/10.2174/187152007781668724","pmid":"https://pubmed.ncbi.nlm.nih.gov/17896913"},"language":"en","primary_location":{"id":"doi:10.2174/187152007781668724","doi":"https://doi.org/10.2174/187152007781668724","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152007781668724","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4230809397"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052708209","display_name":"Aleem Gangjee","orcid":"https://orcid.org/0000-0002-5513-7616","observed_orcids":["https://orcid.org/0000-0002-5513-7616"]},"institutions":[{"id":"https://openalex.org/I165102784","display_name":"Duquesne University","ror":"https://ror.org/02336z538","country_code":"US","type":"education","lineage":["https://openalex.org/I165102784"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aleem Gangjee","raw_affiliation_strings":["Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, USA. gangjee@duq.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, USA. gangjee@duq.edu","institution_ids":["https://openalex.org/I165102784"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057724028","display_name":"Hiteshkumar D. Jain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiteshkumar D. Jain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087840200","display_name":"Sonali Kurup","orcid":"https://orcid.org/0000-0003-4722-7862","observed_orcids":["https://orcid.org/0000-0003-4722-7862"]},"institutions":[{"id":"https://openalex.org/I165102784","display_name":"Duquesne University","ror":"https://ror.org/02336z538","country_code":"US","type":"education","lineage":["https://openalex.org/I165102784"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sonali Kurup","raw_affiliation_strings":["Division of Medicinal Chemistry,Graduate School of Pharmaceutical Sciences, Duquesne University,Pittsburgh, Pennsylvania 15282, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry,Graduate School of Pharmaceutical Sciences, Duquesne University,Pittsburgh, Pennsylvania 15282, USA","institution_ids":["https://openalex.org/I165102784"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7934,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.93769767,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"7","issue":"5","first_page":"524","last_page":"542"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.40209999680519104,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.40209999680519104,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.17960000038146973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.15150000154972076,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.996999979019165},{"id":"https://openalex.org/keywords/thymidylate-synthase-inhibitors","display_name":"thymidylate synthase inhibitors","score":0.902999997138977},{"id":"https://openalex.org/keywords/dihydrofolate-reductase-inhibitors","display_name":"dihydrofolate reductase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/reduced-folate-carrier","display_name":"reduced folate carrier","score":0.9100000262260437},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8289999961853027},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9800000190734863},{"id":"https://openalex.org/keywords/raltitrexed","display_name":"raltitrexed","score":0.9800000190734863},{"id":"https://openalex.org/keywords/trimethoprim","display_name":"trimethoprim","score":0.9869999885559082},{"id":"https://openalex.org/keywords/piritrexim","display_name":"piritrexim","score":0.996999979019165},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7329999804496765},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.9217973351478577},{"id":"https://openalex.org/C2781320022","wikidata":"https://www.wikidata.org/wiki/Q417149","display_name":"Dihydrofolate reductase","level":3,"score":0.8963000774383545},{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.7357938885688782},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.6505507230758667},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5482134222984314},{"id":"https://openalex.org/C2779268555","wikidata":"https://www.wikidata.org/wiki/Q15304877","display_name":"Raltitrexed","level":5,"score":0.5060471892356873},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49869203567504883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.475632905960083},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.4271983504295349},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.39286696910858154},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.15891292691230774},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14783117175102234},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.14060825109481812},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06411948800086975}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000977","descriptor_name":"Antiparasitic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000977","descriptor_name":"Antiparasitic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000977","descriptor_name":"Antiparasitic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010453","descriptor_name":"Peptide Synthases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013762","descriptor_name":"Tetrahydrofolate Dehydrogenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013940","descriptor_name":"Thymidylate Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/187152007781668724","doi":"https://doi.org/10.2174/187152007781668724","is_oa":false,"landing_page_url":"https://doi.org/10.2174/187152007781668724","pdf_url":null,"source":{"id":"https://openalex.org/S159246083","display_name":"Anti-Cancer Agents in Medicinal Chemistry","issn_l":"1568-0118","issn":["1568-0118","1871-5206","1875-5968","1875-5992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Agents in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:17896913","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17896913","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer agents in medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2002810554","https://openalex.org/W4297882644","https://openalex.org/W201774895","https://openalex.org/W2087092768","https://openalex.org/W2402116095","https://openalex.org/W2400059301","https://openalex.org/W2063927417","https://openalex.org/W2055706334","https://openalex.org/W1971343016","https://openalex.org/W2040301739"],"abstract_inverted_index":{"Antifolates":[0],"that":[1,101],"inhibit":[2,64],"the":[3,30,53,91,148,155,162,166,178,196,209],"key":[4],"enzymes":[5],"thymidylate":[6],"synthase":[7],"(TS)":[8],"and":[9,19,25,35,49,60,66,108,112,119,129,138,172,183,198,212,217,220,225,231,245],"dihydrofolate":[10],"reductase":[11],"(DHFR)":[12],"have":[13,98,142,159,186],"found":[14],"clinical":[15],"utility":[16],"as":[17,70,123],"antitumor":[18,71,118,224],"antiopportunistic":[20],"agents.":[21,72],"Methotrexate":[22],"{MTX,":[23],"(1)}":[24],"5-fluorouracil":[26],"(5-FU)":[27],"were":[28],"among":[29],"first":[31],"clinically":[32,68,80],"useful":[33,69,81],"DHFR":[34,185,218],"TS":[36,216],"inhibitors,":[37],"respectively.":[38],"The":[39,175,190],"development":[40],"of":[41,55,76,157,181,200],"resistance":[42,78],"to":[43,79,105,143,203,223],"5-FU,":[44],"its":[45],"occasional":[46],"unpredictable":[47],"activity":[48],"toxicity":[50],"resulted":[51],"in":[52,154,177,239,251],"search":[54],"novel":[56],"antifolates.":[57],"Pemetrexed":[58],"(4)":[59],"raltitrexed":[61],"(5)":[62],"specifically":[63],"TS,":[65,169],"are":[67],"A":[73],"major":[74],"mechanism":[75],"tumor":[77],"antifolates":[82,97,116,158,201,235,247],"is":[83],"based":[84],"on":[85,145,165,195],"their":[86,221],"need":[87,104],"for":[88,117,215],"polyglutamylation":[89],"via":[90],"enzyme":[92],"folylpoly-gamma-glutamate":[93],"synthetase":[94],"(FPGS).":[95],"Novel":[96],"been":[99,188],"developed":[100],"do":[102,140],"not":[103,141],"be":[106,237,249],"polyglutamylated":[107],"include":[109],"plevitrexed":[110],"(6)":[111],"GW1843":[113],"(7).":[114],"Nonclassical":[115],"parasitic":[120,226],"chemotherapy,":[121,227],"such":[122],"nolatrexed":[124],"(8),":[125],"trimethoprim":[126],"{TMP,":[127],"(11)}":[128],"piritrexim":[130],"{PTX,":[131],"(12)},":[132],"can":[133],"passively":[134],"diffuse":[135],"into":[136],"cells":[137],"hence":[139],"depend":[144],"FPGS":[146],"or":[147],"reduced":[149],"folate":[150],"carrier":[151],"(RFC).":[152],"Variations":[153],"structures":[156],"helped":[160],"delineate":[161],"structural":[163,213],"influence":[164],"interaction":[167],"with":[168],"DHFR,":[170],"FPGS,":[171],"RFC":[173],"utilization.":[174],"differences":[176],"active":[179],"site":[180],"human":[182],"pathogen":[184],"also":[187],"exploited.":[189],"literature":[191],"contains":[192],"excellent":[193],"reviews":[194],"design":[197],"synthesis":[199,211],"prior":[202],"1996.":[204,229],"This":[205],"two-part":[206],"review":[207],"discusses":[208],"design,":[210],"requirements":[214],"inhibition":[219],"relevance":[222],"since":[228],"Monocyclic":[230],"6-5":[232],"fused":[233],"bicyclic":[234,244],"will":[236,248],"discussed":[238,250],"Part":[240,252],"I,":[241],"while":[242],"6-6":[243],"tricyclic":[246],"II.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4230809397","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-05-11T00:00:00"}
